91 related articles for article (PubMed ID: 26361147)
1. MicroRNA-203-mediated posttranscriptional deregulation of CPEB4 contributes to colorectal cancer progression.
Zhong X; Xiao Y; Chen C; Wei X; Hu C; Ling X; Liu X
Biochem Biophys Res Commun; 2015 Oct; 466(2):206-13. PubMed ID: 26361147
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
[TBL] [Abstract][Full Text] [Related]
3. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
4. High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer.
He X; Lin X; Cai M; Fan D; Chen X; Wang L; Wu X; Lan P; Wang J
Virchows Arch; 2017 Jan; 470(1):37-45. PubMed ID: 27771769
[TBL] [Abstract][Full Text] [Related]
5. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA miR-125b is a prognostic marker in human colorectal cancer.
Nishida N; Yokobori T; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Kuwano H; Mori M
Int J Oncol; 2011 May; 38(5):1437-43. PubMed ID: 21399871
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
8. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
[TBL] [Abstract][Full Text] [Related]
9. miR-320a suppresses colorectal cancer progression by targeting Rac1.
Zhao H; Dong T; Zhou H; Wang L; Huang A; Feng B; Quan Y; Jin R; Zhang W; Sun J; Zhang D; Zheng M
Carcinogenesis; 2014 Apr; 35(4):886-95. PubMed ID: 24265291
[TBL] [Abstract][Full Text] [Related]
10. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.
Liu L; Chen L; Xu Y; Li R; Du X
Biochem Biophys Res Commun; 2010 Sep; 400(2):236-40. PubMed ID: 20727858
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.
Wu L; Hui H; Wang LJ; Wang H; Liu QF; Han SX
Oncol Rep; 2015 May; 33(5):2309-18. PubMed ID: 25760058
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
[TBL] [Abstract][Full Text] [Related]
13. CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.
Wang HX; Qin R; Mao J; Huang QL; Hong F; Li F; Gong ZY; Xu T; Yan Y; Chao SH; Zhang SK; Chen JX
Clin Neurol Neurosurg; 2018 Jun; 169():92-97. PubMed ID: 29642043
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
15. CPEB4 is a candidate biomarker for defining metastatic cancers and directing personalized therapies.
Xu H; Liu B
Med Hypotheses; 2013 Nov; 81(5):875-7. PubMed ID: 24045092
[TBL] [Abstract][Full Text] [Related]
16. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42.
Li Y; Zhu X; Xu W; Wang D; Yan J
Biochem Biophys Res Commun; 2013 Feb; 431(3):560-5. PubMed ID: 23337504
[TBL] [Abstract][Full Text] [Related]
17. CPEB4 interacts with Vimentin and involves in progressive features and poor prognosis of patients with astrocytic tumors.
Chen W; Hu Z; Li XZ; Li JL; Xu XK; Li HG; Liu Y; Liu BH; Jia WH; Li FC
Tumour Biol; 2016 Apr; 37(4):5075-87. PubMed ID: 26546435
[TBL] [Abstract][Full Text] [Related]
18. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
19. CPEB4 promotes cell migration and invasion via upregulating Vimentin expression in breast cancer.
Lu R; Zhou Z; Yu W; Xia Y; Zhi X
Biochem Biophys Res Commun; 2017 Jul; 489(2):135-141. PubMed ID: 28536077
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
